Viewing nowCombinationEtor Tablet 10/40 mg
Ezetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.

MFDS item code 202101581 · Approved 2021.02.18 · Insurance code 670608750
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This medication helps reduce total cholesterol, LDL-cholesterol, Apo B, triglyceride, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, and increases HDL-cholesterol, which is good cholesterol. It is also used as an adjunct therapy with other treatments for patients with homozygous familial hypercholesterolemia or when other treatments are ineffective. This medication should be used in conjunction with a diet and is employed when non-drug therapies, like limiting saturated fats and cholesterol intake, are insufficient. It is important to identify and treat other causes of dyslipidemia, such as diabetes and hypothyroidism, before therapy. Furthermore, in case of acute coronary events, lipid tests should be promptly conducted upon admission to decide on the treatment direction. This medication is effectively utilized to reduce the risk of vascular diseases associated with hypercholesterolemia.
This medicine is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response to treatment. Primary hypercholesterolemia The dosage range for this medicine is 10/10 mg to 10/80 mg once daily. The recommended initial dose is 10/10 mg or 10/20 mg once daily. For patients who require a greater reduction in LDL cholesterol (55% or more), the recommended initial dose is 10/40 mg once daily. After starting this medicine or adjusting the dose, blood lipid levels should be checked at intervals of at least 2 weeks, and the dose adjusted accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg or 10/80 mg once daily. This medicine is administered as an adjunct to other lipid-lowering therapy (e.g., LDL-Apheresis), or when other lipid-lowering therapies are not useful.
This medication has been reported to cause a rare side effect called rhabdomyolysis, which can cause serious damage to muscles. In particular, patients presenting with severe muscle symptoms or renal issues should temporarily discontinue or stop taking this medication. Patients with an allergy to any component of this medication or those with liver issues, muscle disorders, pregnant or nursing women should not take this medication. Additionally, certain liver disease patients or those taking specific medications should also avoid using this medication. Alcoholics or patients with poor liver function and those at high risk of muscle disorders should take this medication with caution, especially elderly patients need to be careful. This medication may affect liver function, thus it is important to undergo regular liver function tests before and during treatment. Symptoms like muscle pain, abdominal pain, and increased liver enzymes are common side effects, and any abnormal symptoms should be reported to a doctor immediately. This medication may interact with other drugs, so patients should disclose any medications they are taking. Special caution is needed when taken with drugs that can cause muscle damage. Women of childbearing age should use appropriate contraceptive methods to avoid pregnancy during the use of this medication and must stop taking it immediately if pregnancy is confirmed. Symptoms like dizziness may occur, so caution is advised when driving or operating machinery. This medication is not recommended for children as its safety and efficacy have not been established for pediatric use. In the case of overdose, there is no specific antidote, so symptomatic treatment should be provided, and monitoring of liver function and muscle condition is necessary. This medication should be kept out of reach of children and should not be transferred to other containers.
Acute renal failure due to myoglobinuria, rhabdomyolysis, myalgia, abdominal pain, elevated liver enzymes, increased ALT, increased AST, musculoskeletal pain, dizziness, cough, nausea, arthralgia, muscle weakness, hyperkalemia, bronchitis, sinusitis, flushing, intracranial aneurysm, restless legs syndrome, depression, bronchiolitis, dental abscess, vestibular neuritis, bradycardia, hypotension, anemia, hernia, vitamin D deficiency, gastric polyps, duodenal polyps, duodenitis, jaundice, erectile dysfunction, breast mass, skin mass, ingrown toenails, thyroid adenoma, fatigue, malaise, chest pain, peripheral edema, tiredness, fever, nasopharyngitis, hyperglycemia, hypoglycemia, weight gain, loss of appetite, constipation, abdominal distension, dyspepsia, diarrhea, vomiting, belching, pancreatitis, pharyngeal and laryngeal pain, nosebleeds, insomnia, nightmares, headache, paresthesia, sensory loss, dysgeusia, amnesia, peripheral neuropathy, muscle cramps, joint swelling, back pain, neck pain, muscle fatigue, complications from rupture, myopathy, myositis, tendon disorders, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, thrombocytopenia, allergic reactions, anaphylaxis, hepatitis, cholestasis, liver failure, blurred vision, visual impairment, tinnitus, hearing loss, urticaria, skin rash, itching, hair loss, angioedema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, gynecomastia, urinary tract infection, frequent urination, cystitis, hematuria, dysuria, kidney stones, nocturia, epididymitis, breast fibrocystic disease, vaginal bleeding, albuminuria, breast enlargement, cervical discharge, nephritis, urinary incontinence, urinary retention, urgency, abnormal ejaculation, uterine bleeding, discolored urine, increased appetite, malaise, vasogenic edema, chest pain, angina, facial edema, fever, neck stiffness, generalized edema, amblyopia, dry eyes, refractive errors, eye hemorrhage, hearing loss, glaucoma, altered sense of taste, taste distortion, leukopenia, decreased testosterone, increased cholinesterase, elevated TSH, increased ACTH, decreased aldosterone, elevated potassium, increased BUN, cerebral infarction, palpitations, tachycardia, positive leukocytes in urine, intracranial aneurysm, restless legs syndrome, depression, bronchiolitis, dental abscess, vestibular neuritis, bradycardia, hypotension, anemia, hernia, hyperkalemia, vitamin D deficiency, gastric polyps, duodenal polyps, duodenitis, jaundice, erectile dysfunction, breast mass, skin mass, ingrown toenails, thyroid adenoma, sleep disturbances, amnesia, interstitial lung disease, sexual dysfunction, diabetes, cognitive impairment, myasthenia gravis, ocular myasthenia, liver failure, hepatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, drug reaction with eosinophilia and systemic symptoms, severe cutaneous adverse reactions, fatigue, chest pain, chest discomfort, edema, weakness, generalized edema, headache, diabetic neuropathy, tremors, upper abdominal pain, vomiting, gastritis, constipation, dry mouth, epigastric discomfort, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, cough, sputum, runny nose, limb pain, arthralgia, diabetes, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, rash, itching, upper respiratory infection, conjunctival injection, renal failure, abnormal liver function, increased serum creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function tests
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air and moisture ingress and should be maintained at room temperature between 1 degree and 30 degrees. Proper storage will help retain the medication's effectiveness.
White oblong film-coated tablet
30 tablets/PTP [(10 tablets/PTP package (Alu-Alu) x 3)], 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.